Abstract
Using microdialysis in a rabbit model of Streptococcus pneumoniae meningitis, the pharmacokinetics and pharmacodynamics of a new fluoroquinolone, A-80556, were determined. A-80556 (10 mg/kg iv) was administered to four rabbits. Saline was given to four separate control animals. A microdialysis probe perfused the CSF (2 μL/min) and effluent was collected at 0-0.25, 0.25-1, 1-2, 2-4, and 4-6 h after injection of A-80556. Seven blood samples were collected and analyzed by HPLC. At 0, 2, 4, and 6 h 300 μL of CSF was withdrawn for pharmacodynamic measurements. Plasma A-80556 concentrations demonstrated AUC(0-∞), 2.40 ± 0.272 μg.h/mL; T( 1/4 β) 1.07 ± 0.011 h; V(d) 6.35 ± 0.50 L/kg; and Cl(t), 4.23 ± 0.48 L/h.kg. Penetration into the CSF was 18.21%. Pharmacodynamics using time-kill curves showed a 3-log reduction in bacterial counts in CSF at 2 h after administration continuing for the remaining four hours of the experiment. These results demonstrate that microdialysis can be used for determination of drug penetration and efficacy in experimental S. pneumoniae meningitis.
| Original language | English |
|---|---|
| Pages (from-to) | 977-985 |
| Number of pages | 9 |
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 38 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 1996 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology
- Microbiology
Cite this
Pharmacodynamics and pharmacokinetics of A-80556 using microdialysis in a Streptococcus pneumoniae meningitis model. / Destache, Christopher J.; Pakiz, Catherine B.; Stoysich, Anne M.
In: Journal of Antimicrobial Chemotherapy, Vol. 38, No. 6, 12.1996, p. 977-985.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pharmacodynamics and pharmacokinetics of A-80556 using microdialysis in a Streptococcus pneumoniae meningitis model
AU - Destache, Christopher J.
AU - Pakiz, Catherine B.
AU - Stoysich, Anne M.
PY - 1996/12
Y1 - 1996/12
N2 - Using microdialysis in a rabbit model of Streptococcus pneumoniae meningitis, the pharmacokinetics and pharmacodynamics of a new fluoroquinolone, A-80556, were determined. A-80556 (10 mg/kg iv) was administered to four rabbits. Saline was given to four separate control animals. A microdialysis probe perfused the CSF (2 μL/min) and effluent was collected at 0-0.25, 0.25-1, 1-2, 2-4, and 4-6 h after injection of A-80556. Seven blood samples were collected and analyzed by HPLC. At 0, 2, 4, and 6 h 300 μL of CSF was withdrawn for pharmacodynamic measurements. Plasma A-80556 concentrations demonstrated AUC(0-∞), 2.40 ± 0.272 μg.h/mL; T( 1/4 β) 1.07 ± 0.011 h; V(d) 6.35 ± 0.50 L/kg; and Cl(t), 4.23 ± 0.48 L/h.kg. Penetration into the CSF was 18.21%. Pharmacodynamics using time-kill curves showed a 3-log reduction in bacterial counts in CSF at 2 h after administration continuing for the remaining four hours of the experiment. These results demonstrate that microdialysis can be used for determination of drug penetration and efficacy in experimental S. pneumoniae meningitis.
AB - Using microdialysis in a rabbit model of Streptococcus pneumoniae meningitis, the pharmacokinetics and pharmacodynamics of a new fluoroquinolone, A-80556, were determined. A-80556 (10 mg/kg iv) was administered to four rabbits. Saline was given to four separate control animals. A microdialysis probe perfused the CSF (2 μL/min) and effluent was collected at 0-0.25, 0.25-1, 1-2, 2-4, and 4-6 h after injection of A-80556. Seven blood samples were collected and analyzed by HPLC. At 0, 2, 4, and 6 h 300 μL of CSF was withdrawn for pharmacodynamic measurements. Plasma A-80556 concentrations demonstrated AUC(0-∞), 2.40 ± 0.272 μg.h/mL; T( 1/4 β) 1.07 ± 0.011 h; V(d) 6.35 ± 0.50 L/kg; and Cl(t), 4.23 ± 0.48 L/h.kg. Penetration into the CSF was 18.21%. Pharmacodynamics using time-kill curves showed a 3-log reduction in bacterial counts in CSF at 2 h after administration continuing for the remaining four hours of the experiment. These results demonstrate that microdialysis can be used for determination of drug penetration and efficacy in experimental S. pneumoniae meningitis.
UR - http://www.scopus.com/inward/record.url?scp=0030451596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030451596&partnerID=8YFLogxK
U2 - 10.1093/jac/38.6.977
DO - 10.1093/jac/38.6.977
M3 - Article
C2 - 9023645
AN - SCOPUS:0030451596
VL - 38
SP - 977
EP - 985
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
SN - 0305-7453
IS - 6
ER -